26 October 2017 EMA/722339/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: human plasma (pooled and treated for virus inactivation)

Procedure no.: PSUSA/00001635/201702

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in

MRP/DCP

National Authorisation

MAH of product in the

Member State where

authorisation country)

Authorisation number

Number

Member State

product is authorised

OCTAPLAS® SD* Blutgruppe A zur Infusion

not available

2-00137

AT

20150313

OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESMBH OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESMBH OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESMBH OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESMBH OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESMBH OCTAPHARMA BENELUX S.A./N.V. OCTAPHARMA (IP)-LTD.

OCTAPLAS® SD* Blutgruppe B zur Infusion

not available

2-00138

OCTAPLAS® SD* Blutgruppe AB not available zur Infusion

2-00139

OCTAPLAS® SD* Blutgruppe 0 zur Infusion

not available

2-00140

Octaplas LG 45-70 mg/ml Infusionslösung

UK/H/0355/001

236510

octaplasLG, solution pour perfusion octaplasLG, 45–70 mg/ml solution for infusion octaplasLG Octaplas Octaplas® LG OctaplasLG, infusionsvæske, opløsning OctaplasLG, infusionsvæske, opløsning OctaplasLG, infusionsvæske, opløsning OctaplasLG, infusionsvæske, opløsning OctaplasLG, 45...70 mg/ml, infusioonilahus OctaplasmaLG (0) 45 - 70 mg/ml solución para perfusión OctaplasmaLG (A) 45 - 70 mg/ml solución para perfusión

UK/H/0355/001

BE222713

UK/H/0355/001 UK/H/0355/001 not available not available UK/H/0355/001

75/266/16-C 75/038/03-C PEI.H.02698.01.1 58093

OCTAPHARMA OCTAPHARMA OCTAPHARMA OCTAPHARMA

CZ CZ DE DK

UK/H/0355/001

58094

OCTAPHARMA AB

DK

UK/H/0355/001

58095

OCTAPHARMA AB

DK

UK/H/0355/001

58096

OCTAPHARMA AB

DK

UK/H/0355/001

888615

OCTAPHARMA (IP)-LTD.

EE

UK/H/0355/001

80563

OCTAPHARMA S.A.

ES

UK/H/0355/001

81078

OCTAPHARMA S.A.

ES

List of nationally authorised medicinal products EMA/722339/2017

(IP)-LTD. (IP)-LTD. GMBH AB

AT AT AT AT BE BG

Page 2/4

Product Name (in

MRP/DCP

National Authorisation

MAH of product in the

Member State where

authorisation country)

Authorisation number

Number

Member State

product is authorised

OctaplasmaLG (B) 45 - 70 mg/ml solución para perfusión OctaplasmaLG (AB) 45 - 70 mg/ml solución para perfusión octaplasLG OCTAPLASLG, solution pour perfusion OCTAPLASLG, solution pour perfusion OCTAPLASLG, solution pour perfusion OCTAPLASLG, solution pour perfusion octaplasLG 45-70 mg/ml otopina za infuziju OctaplasLG 45-75 mg/ml oldatos infúzió Octaplas fagyasztott oldatos infúzió Octaplas fagyasztott oldatos infúzió Octaplas fagyasztott oldatos infúzió Octaplas fagyasztott oldatos infúzió LG-octaplas solution for infusion PLASMAGRADE soluzione per infusione PLASMASAFE soluzione per infusione Octaplas

UK/H/0355/001

81079

OCTAPHARMA S.A.

ES

UK/H/0355/001

81080

OCTAPHARMA S.A.

ES

UK/H/0355/001 UK/H/0355/001

15619 34009 550 030 9 0

OCTAPHARMA AB OCTAPHARMA FRANCE

FI FR

UK/H/0355/001

34009 550 031 0 6

OCTAPHARMA FRANCE

FR

UK/H/0355/001

34009 550 031 1 3

OCTAPHARMA FRANCE

FR

UK/H/0355/001

34009 550 031 2 0

OCTAPHARMA FRANCE

FR

UK/H/0355/001

HR-H-098600779

OCTAPHARMA (IP)-LTD.

HR

UK/H/0355/001

OGYI-T-20223/05

OCTAPHARMA (IP)-LTD.

HU

not available

OGYI-T-20223/02

OCTAPHARMA (IP)-LTD.

HU

not available

OGYI-T-20223/03

OCTAPHARMA (IP)-LTD.

HU

not available

OGYI-T-20223/04

OCTAPHARMA (IP)-LTD.

HU

not available

OGYI-T-20223/01

OCTAPHARMA (IP)-LTD.

HU

UK/H/0355/001 not available

PA 521/4/2 041868011

OCTAPHARMA-LTD KEDRION S.P.A.

IE IT

not available

033369012

KEDRION S.P.A.

IT

not available

octaplasma infuzinis tirpalas octaplasLG

UK/H/0355/001 UK/H/0355/001

AIC N. 034540017; AIC N. 533 OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESMBH LT/1/15/3801/001 OCTAPHARMA (IP)-LTD. 0345205 (NATIONAL); OCTAPHARMA BENELUX 1196/09050311 (AMM) S.A./N.V.

List of nationally authorised medicinal products EMA/722339/2017

IT LT LU

Page 3/4

Product Name (in

MRP/DCP

National Authorisation

MAH of product in the

Member State where

authorisation country)

Authorisation number

Number

Member State

product is authorised

octaplasma šķīdums infūzijām octaplasLG, solution for infusion Omniplasma Octaplasma 45-70 mg/ml infusjonsvæske, oppløsning octaplasLG, roztwór do infuzji Octaplas

UK/H/0355/001 UK/H/0355/001 UK/H/0355/001 UK/H/0355/001

15-0256 MA754/00901 RVG 25407 14-10475

UK/H/0355/001 not available

22806 2830487

Novoplas (AB Plasma)

not available

OctaplasLG soluţie perfuzabilă

UK/H/0355/001

OctaplasLG soluţie perfuzabilă

UK/H/0355/001

OctaplasLG soluţie perfuzabilă

UK/H/0355/001

OctaplasLG soluţie perfuzabilă

UK/H/0355/001

octaplasLG, infusionsvätska lösning octaplasLG 45-70 mg/ml raztopina za infundiranje octaplasLG 45-70 mg/ml raztopina za infundiranje octaplasLG 45-70 mg/ml raztopina za infundiranje octaplasLG Octaplasma 45 – 70 mg/ml infúzny roztok octaplasLG, solution for infusion

OCTAPHARMA OCTAPHARMA OCTAPHARMA OCTAPHARMA

(IP)-LTD. (IP)-LTD. GMBH AS

LV MT NL NO PL PT

UK/H/0355/001

OCTAPHARMA (IP)-LTD. OCTAPHARMA PRODUTOS FARMACEUTICOS, LDA. 5319686 OCTAPHARMA PRODUTOS FARMACEUTICOS, LDA. 8288/2015/01 (BLOOD GROUP OCTAPHARMA (IP)-LTD. A) 8288/2015/02 (BLOOD GROUP OCTAPHARMA (IP)-LTD. B) 8288/2015/03 (BLOOD GROUP OCTAPHARMA (IP)-LTD. AB) 8288/2015/04 (BLOOD GROUP OCTAPHARMA (IP)-LTD. 0) 16273 OCTAPHARMA AB

UK/H/0355/001

H/16/02216/001

OCTAPHARMA (IP)-LTD.

SI

UK/H/0355/001

H/16/02216/002

OCTAPHARMA (IP)-LTD.

SI

UK/H/0355/001

H/16/02216/003

OCTAPHARMA (IP)-LTD.

SI

UK/H/0355/001 UK/H/0355/001

H/16/02216/004 75/0190/16-S

OCTAPHARMA (IP)-LTD. OCTAPHARMA (IP)-LTD.

SI SK

UK/H/0355/001

PL 10673/0009

OCTAPHARMA-LTD

UK

List of nationally authorised medicinal products EMA/722339/2017

PT RO RO RO RO SE

Page 4/4

human plasma (pooled and treated for virus inactivation): List of ...

Page 1. Page 2. Page 3. Page 4. ki Å« ā. OctaplasLG soluție perfuzabilă. OctaplasLG soluție perfuzabilă. OctaplasLG soluție perfuzabilă. SLG soluție ...

108KB Sizes 0 Downloads 207 Views

Recommend Documents

Updated Recommendations for Human Immunodeficiency Virus
Jun 10, 2016 - (MSM) in Clinical Settings: Updated Recommendations. Subject of Planned Report: This report will outline the current scientific data regarding ...

Determination of Codeine in Human Plasma and Drug ...
PM-80 solvent delivery system, a Rheodyne Model 7125 sample injection valve (20 mL ... the content of codeine in real samples. Human plasma was ... SW voltammograms for 10 mM codeine in 0.05 M HClO4 solution at a bare GCE (a), the ...

Validation of a Commercial Process for Inactivation of ... - Meat HACCP
ANNA C. S. PORTO-FETT, JEFFREY E. CALL, AND JOHN B. LUCHANSKY*. U.S. Department of Agriculture, Agricultural Research Service, Eastern Research ...

Ribavirin, human convalescent plasma and anti-b3 ... - CiteSeerX
New Mexico School of Medicine, Albuquerque, NM 87131, USA. 2Lovelace ...... support for renewed efforts to evaluate the drug in treatment protocols.

Human Immunodeficiency Virus article Arjun & Neha.pdf ...
Human Immunodeficiency Virus article Arjun & Neha.pdf. Human Immunodeficiency Virus article Arjun & Neha.pdf. Open. Extract. Open with. Sign In.

Validation of a Commercial Process for Inactivation of ... - Meat HACCP
O157:H7. 4. JBL2139 C7927. Clinical isolate, 1991 Massachusetts apple cider out- ... of beef were sliced by our collaborator (Wild Bill's Foods, Inc.,. Leola, Pa.) ...

Inactivation of Mitotic Kinase Triggers Translocation of MEN ...
processed using the Autodeblur software from AutoQuant Imaging. For calcofluor staining, cells .... identical to that described in A and were ana- lyzed similarly.

the development of erectile dysfunction in men treated for prostate ...
Purpose: Erectile dysfunction is a common side effect in men treated for prostate cancer. Previously published studies document the incidence of erectile ...

Plasma polymerized TEOS films for
tel: 00 213 079632647, email : [email protected]. Received: February 18 ... Concerning the selectivity, the results revealed a good affinity of the layer to methanol ...

Inactivation of Mitotic Kinase Triggers Translocation of MEN ...
Exit from mitosis is regulated by the mitotic exit network. (MEN), which ... cytokinesis. These cells can assemble and constrict the actomyosin ring normally but are incapable of forming a septum, ..... Dbf20-YFP signal is much weaker compared.

Mapping the Human Plasma Proteome by SCX-LC-IMS-MS
bines strong-cation-exchange (SCX), reverse-phase liq- ... E-mail: [email protected]. Published .... analyses of each fraction using a home built LC-IMS-MS.

Development of a method for total plasma thiols ...
ease in automation and high sensitivity [18–21]. However, such. ∗ Corresponding author. E-mail address: [email protected] (J.-M. Zen). methods ...

new insights into human immunodeficiency virus - type ...
replication, namely how the virus recognizes and enters the target cell, the ... into active regions of the cellular genome ..... Best S., Tissier P., Towers G. et al.

high-temperature superconductivity in water-treated graphite ...
Page 1 of 19. 1. The following article has been published in final form at: http://onlinelibrary.wiley.com/doi/10.1002/adma.201202219/abstract. Can doping graphite trigger room temperature superconductivity? Evidence for granular high-temperature sup

Andes virus - Centers for Disease Control and Prevention
tal, Santiago, Chile; and ‡University of New Mexico Health Sciences. Center .... The authors are grateful to O. Roos for excellent technical assis- .... California.

Design of Z-pinch and Dense Plasma Focus Powered Vehicles
Z-pinch and Dense Plasma Focus (DPF) are two promising techniques for bringing fusion power to the field of in-space propulsion. A design team comprising of ...

Evaluation of plasma damage in blanket and patterned ...
low-k agree well with the FTIR and water source ellipsometric porosimetry (WEP) ... be used for the real-time process optimization and monitoring. Therefore, it is ...

scan pdf for virus online
... doesn't start automatically. Page 1 of 1. scan pdf for virus online. scan pdf for virus online. Open. Extract. Open with. Sign In. Main menu. Displaying scan pdf ...